Hims & Hers Health stock price forecast: Facing $21.38 resistance as HIMS sees continued weakness

Traders Union
All News
Financial News
Hims & Hers Health drops 1.24% today

Highlights

HIMS is trading below key moving averages and faces persistent downward pressure across all timeframes.
Momentum indicators signal broad weakness with pronounced selling activity and only minor conflicting signs of short-term buyer interest.
Expected trading range for the next five days is $17.25–$21.05, with risk skewed toward further downside unless $21.38 is reclaimed.

Weak momentum and conflicting signals as sellers dominate

Momentum signals are broadly negative, with MACD firmly in sell territory, while ADX shows weak trend strength. RSI (44.78), CCI (–71.45), and Stoch RSI (22.77) all suggest oversold to weak momentum, though BBP is overbought at 0.63, highlighting conflicting intraday signals. There was virtually no gap at the open, but the price slipped 1.24% on the day and is now near the lower end of today’s range amid moderate volatility, reflecting persistent selling pressure after the open; this aligns with weak momentum, despite BBP’s sign of residual buyer activity.

Decline risk heightened as technicals favor further downside

For the next five trading days, the expected trading range is adjusted to $17.25 – $21.05, reflecting a typical range for this price level and current volatility conditions. There is a very low probability (less than 20%) of a price increase, while a further decline is more likely, given the uniform sell signals across D1 and W1 RSI, MACD, MA-50, and relatively neutral ADX readings. The baseline scenario anticipates sideways movement between support and resistance. Bullish momentum would require a breakout above $21.38, while a sustained move below $18.96 would confirm a bearish extension.

Anton Kharitonov, expert at Traders Union, sees Hims & Hers Health Inc trapped under key moving averages, with technical signals stressing persistent downward pressure. He notes momentum remains weak across most indicators, and the lack of positive news flow underscores the bearish tone. The analyst believes a further decline is likely unless resistance at $21.38 is broken. "Base case remains for a sideways to lower move — I stay cautious until bulls retake $21.38."

Earlier, analysts noted that Hims & Hers Health remained under persistent downside momentum due to prevailing technical and regulatory pressures. The latest technical setup reinforces this bearish outlook, with traders advised to closely monitor the $18.96 support level for signs of further weakness or a potential inflection point.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.